Monday, May 27, 2013

Changes Eyed To Senate Compounding Bill Could Exempt Home Infusion Senators and stakeholders are considering potential changes to the upper chamber's drug compounding bill -- particularly the bill's current pooling and repackaging definitions that stakeholders worry could bring home infusion providers under the new regulatory category for compounding manufacturers and . . .

No comments: